Related Experiment Video
Updated: Aug 7, 2026

In Situ Detection of Bacteria within Paraffin-embedded Tissues Using a Digoxin-labeled DNA Probe Targeting 16S rRNA
Published on: May 21, 2015
Anti-cardiolipin antibodies in sera from patients with periodontitis
H A Schenkein1, C R Berry, J A Burmeister
1Clinical Research Center for Periodontal Disease, Virginia Commonwealth University, School of Dentistry, PO Box 980566, Richmond, VA 23298-0566, USA. haschenk@vcu.edu
Insights
Patients with periodontitis show higher levels of antiphospholipid antibodies, specifically beta2-glycoprotein I-dependent anti-cardiolipin autoantibodies (anti-CL). These antibodies are linked to increased periodontal damage and potential risks for stroke and adverse pregnancy outcomes.
Area of Science:
- Immunology
- Periodontology
- Cardiovascular Health
Background:
- Antiphospholipid antibodies (aPL) are linked to thrombosis and pregnancy complications.
- aPL are frequently observed in systemic lupus erythematosus and antiphospholipid syndrome.
- The association between aPL and periodontal disease requires further investigation.
Purpose of the Study:
- To investigate the prevalence of beta2-glycoprotein I-dependent anti-cardiolipin autoantibodies (anti-CL) in patients with varying periodontal disease status.
- To determine if anti-CL autoantibodies correlate with periodontal disease severity.
- To explore the potential systemic health implications of anti-CL in periodontitis patients.
Main Methods:
- Serum samples from 411 patients were analyzed for anti-CL autoantibodies.
- Patients were clinically assessed for periodontal disease status (chronic periodontitis, generalized aggressive periodontitis, localized aggressive periodontitis, and healthy controls).
- Periodontal parameters including pocket depth and attachment loss were measured.
Main Results:
- Prevalence of anti-CL positive patients was significantly higher in chronic periodontitis (16.2%) and generalized aggressive periodontitis (19.3%) compared to healthy controls (6.8%) and localized aggressive periodontitis (3.2%).
- Patients with anti-CL autoantibodies exhibited greater pocket depth and attachment loss.
- Elevated levels of autoantibodies reactive with phospholipids were found in generalized periodontitis patients.
Conclusions:
- Generalized periodontitis is associated with elevated levels of antiphospholipid antibodies.
- These antibodies may contribute to an increased risk of systemic conditions such as stroke, atherosclerosis, and preterm birth in periodontitis patients.
- Further research is warranted to elucidate the causal relationship and clinical significance of aPL in periodontal disease.
Abstract:
Antiphospholipid antibodies are commonly found in patients with systemic lupus erythematosus or the antiphospholipid syndrome, and a subset of such antibodies is associated with prothrombotic events such as stroke and with adverse pregnancy outcomes and fetal loss. We examined sera from 411 patients who were clinically characterized as to their periodontal disease status for serum levels of beta2-glycoprotein I-dependent anti-cardiolipin autoantibodies (anti-CL). The prevalence of patients with chronic periodontitis (CP) and generalized aggressive periodontitis (GAgP) positive for anti-CL (16.2% and 19.3%, respectively) was greater than that in healthy controls (NP) and localized aggressive periodontitis (LAgP) patients (6.8% and 3.2%). Patients with these autoantibodies demonstrated increased pocket depth and attachment loss compared with patients lacking the antibodies. Analysis of the data indicates that patients with generalized periodontitis have elevated levels of autoantibodies reactive with phospholipids. These antibodies could be involved in elevated risk for stroke, atherosclerosis, or pre-term birth in periodontitis patients.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis I: Introduction
Pericarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease I: Introduction

